A

Assertio Holdings Inc
NASDAQ:ASRT

Watchlist Manager
Assertio Holdings Inc
NASDAQ:ASRT
Watchlist
Price: 0.98 USD 0.1%
Market Cap: 93.4m USD
Have any thoughts about
Assertio Holdings Inc?
Write Note

Assertio Holdings Inc
Intangible Assets

Last Value
3-Years 3-Y CAGR
5-Years 5-Y CAGR
10-Years 10-Y CAGR
Quarterly
Annual
|

Assertio Holdings Inc
Intangible Assets Peer Comparison

Competitors Analysis
Latest Figures & CAGR of Competitors

Company Intangible Assets CAGR 3Y CAGR 5Y CAGR 10Y
A
Assertio Holdings Inc
NASDAQ:ASRT
Intangible Assets
$92.4m
CAGR 3-Years
-20%
CAGR 5-Years
-32%
CAGR 10-Years
2%
Johnson & Johnson
NYSE:JNJ
Intangible Assets
$39.5B
CAGR 3-Years
-6%
CAGR 5-Years
-4%
CAGR 10-Years
4%
Bristol-Myers Squibb Co
NYSE:BMY
Intangible Assets
$27B
CAGR 3-Years
-16%
CAGR 5-Years
93%
CAGR 10-Years
32%
Pfizer Inc
NYSE:PFE
Intangible Assets
$61.2B
CAGR 3-Years
33%
CAGR 5-Years
9%
CAGR 10-Years
5%
Merck & Co Inc
NYSE:MRK
Intangible Assets
$17B
CAGR 3-Years
8%
CAGR 5-Years
7%
CAGR 10-Years
-2%
Eli Lilly and Co
NYSE:LLY
Intangible Assets
$6.5B
CAGR 3-Years
-6%
CAGR 5-Years
0%
CAGR 10-Years
3%
No Stocks Found

Assertio Holdings Inc
Glance View

Market Cap
93.5m USD
Industry
Pharmaceuticals

Assertio Holdings, Inc. engages in the provision of commercial pharmaceutical products. The company is headquartered in Lake Forest, Illinois and currently employs 19 full-time employees. The firm's primary marketed products are INDOCIN (indomethacin) Suppositories, INDOCIN (indomethacin) Oral Suspension, INDOCIN (indomethacin) Oral Suspension, CAMBIA (diclofenac potassium for oral solution), Otrexup (methotrexate) injection for subcutaneous use, SPRIX (ketorolac tromethamine) Nasal Spray and Zipsor (diclofenac potassium) Liquid filled capsules. The firm has other commercially available products, which include OXAYDO (oxycodone HCI, USP) tablets for oral use only. Assertio and Zyla are the registered trademarks of the Company. INDOCIN products are used for the treatment of moderate to severe rheumatoid arthritis, including acute flares of chronic disease, moderate to severe ankylosing spondylitis, moderate to severe osteoarthritis, acute painful shoulder (bursitis and/or tendinitis) and acute gouty arthritis.

ASRT Intrinsic Value
1.56 USD
Undervaluation 37%
Intrinsic Value
Price
A

See Also

What is Assertio Holdings Inc's Intangible Assets?
Intangible Assets
92.4m USD

Based on the financial report for Sep 30, 2024, Assertio Holdings Inc's Intangible Assets amounts to 92.4m USD.

What is Assertio Holdings Inc's Intangible Assets growth rate?
Intangible Assets CAGR 10Y
2%

Over the last year, the Intangible Assets growth was -46%. The average annual Intangible Assets growth rates for Assertio Holdings Inc have been -20% over the past three years , -32% over the past five years , and 2% over the past ten years .

Back to Top